Log in to save to my catalogue

Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy

Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9408992

Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy

About this item

Full title

Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy

Author / Creator

Publisher

Basel: MDPI AG

Journal title

International journal of molecular sciences, 2022-08, Vol.23 (16), p.9341

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Cyclophilin A (CypA), which has peptidyl–prolyl cis-trans isomerase (PPIase) activity, regulates multiple functions of cells by binding to its extracellular receptor CD147. The CypA/CD147 interaction plays a crucial role in the progression of several diseases, including inflammatory diseases, coronavirus infection, and cancer, by activating CD147-m...

Alternative Titles

Full title

Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9408992

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9408992

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms23169341

How to access this item